Patent US5366869A successfully refreshed from Google Patents.
US5366869A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Multiple coagulation test device and method
Assignee: COAGULATION SCIENCES LLC
•
Filing: 1991-11-08
•
Granted: 1994-11-22
•
Expires: 2011-11-08
Abstract
Abstract A multiple coagulation test device has a plurality of tubes, each tube having associated coagulation detection means, and containing a treatment dosage of a coagulation enhancing agent. Whole blood samples are placed in the tubes which are mixed and warmed to 37° C., with the time to coagulation determined. The agent giving the lowest clotting time is selected as the most effective treatment for reducing hemorrhaging within a few minutes and the selected treatment begun. Utilizing the inventive device eliminates the need to use a multiple agent approach, by identifying the most effective course of action.
Inventors
- 👤 Sheldon Goldstein
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 18:03
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/483; G01N33/487; G01N33/49; G01N33/4905; C; C12; C12Q; C12Q1/00; C12Q1/56; Y; Y10; Y10T; Y10T436/00; Y10T436/10; Y10T436/106664
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
90 words
A method for determining the treatment required to arrest hemorrhaging in a patient comprising a) providing a series of different agents capable of enhancing blood clotting; b) obtaining a series of samples of the patient's blood; c) mixing a sample of blood with each of the individual agents to prepare a series of mixtures, each mixture of said series containing a different agent; d) simultaneously measuring the clotting time for each mixture in said series; and e) selecting the agent in said series which produces the most rapid clotting time.
Claim 2
Independent Claim
90 words
A method for determining the treatment required to arrest hemorrhaging in a patient comprising a) providing a series of different agents capable of enhancing blood clotting; b) obtaining a series of samples of the patient's blood; c) mixing a sample of blood with each of the individual agents to prepare a series of mixtures, each mixture of said series containing a different agent; d) simultaneously measuring the clotting time for each mixture in said series; and e) selecting the agent in said series which produces the most rapid clotting time.
Claim 3
Dependent Claim
41 words
The method of claim 1 wherein the blood clotting enhancing agent is selected from the group consisting of coagulation factors, platelets, plasminogen activator, desmopressin acetate (DDAVP), epsilo-amino caproic acid, protamine, aprotinin, fibronectin, thrombin, plasminogen, plasma, a cryoprecipitated plasma product and prostacyclin.
Claim 4
Dependent Claim
40 words
The method of claim 2 wherein the coagulation factor is coagulation factor I (fibrinogen), Ia (fibrin), II (prothrombin), IIa (thrombin), III (thromboplastin), IV, V, VI, VII, VIII, IX, X, XI, XII, VIII:C, von Willebrand factor or a bovine coagulation factor.
Claim 5
Dependent Claim
16 words
The method of claim 2 wherein the plasma is bovine plasma, or human fresh frozen plasma.
Claim 6
Independent Claim
102 words
A method for arresting hemorrhaging in a patient comprising a) providing a series of different agents capable of enhancing blood clotting; b) obtaining a series of samples of the patient's blood; c) mixing a sample of blood with each of the individual agents to prepare a series of mixtures, each mixture of said series containing a different agent; d) simultaneously measuring the clotting time for each mixture in said series; e) selecting the agent in said series which produces the most rapid clotting time; and f) administering a blood clotting effective amount of the selected agent from step e) to the patient.
Claim 7
Independent Claim
102 words
A method for arresting hemorrhaging in a patient comprising a) providing a series of different agents capable of enhancing blood clotting; b) obtaining a series of samples of the patient's blood; c) mixing a sample of blood with each of the individual agents to prepare a series of mixtures, each mixture of said series containing a different agent; d) simultaneously measuring the clotting time for each mixture in said series; e) selecting the agent in said series which produces the most rapid clotting time; and f) administering a blood clotting effective amount of the selected agent from step e) to the patient.
Claim 8
Dependent Claim
41 words
The method of claim 5 wherein the blood clotting enhancing agent is selected from the group consisting of coagulation factors, platelets, plasminogen activator, desmopressin acetate (DDAVP), epsilo-amino caproic acid, protamine, aprotinin, fibronectin, thrombin, plasminogen, plasma, a cryoprecipitated plasma product and prostacyclin.
Claim 9
Dependent Claim
40 words
The method of claim 6 wherein the coagulation factor is coagulation factor I (fibrinogen), Ia (fibrin), II (prothrombin), IIa (thrombin), III (thromboplastin) IV, V, VI, VII, VIII, IX, X, XI, XII, VIII:C, von Willebrand factor or a bovine coagulation factor.
Claim 10
Dependent Claim
16 words
The method of claim 6 wherein the plasma is bovine fresh frozen plasma, or human plasma.
References Cited (Backward Citations)
US2616796A
Cited
US3302452A
Cited
US3836333A
Cited
US3695482A
Cited
US4135819A
Cited
US3918908A
Cited
US4125327A
Cited
US4074971A
Cited
US4000972A
Cited
US4105411A
Cited
US4659550A
Cited
US4497774A
Cited
US4671939A
Cited
US4443408A
Cited
US4534939A
Cited
US4599219A
Cited
US4663127A
Cited
US4752449A
Cited
US4640896A
Cited
US4782026A
Cited
US4871677A
Cited
US4946775A
Cited
DE3540661A1
Cited
US4865984A
Cited
WO1989010788A1
Cited
WO1991001383A1
Cited
WO1991016453A1
Cited
US5302348A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-11-21 | 1998-05-23 | 1998-11-22 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-11-21 | 2002-05-23 | 2002-11-22 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-11-21 | 2006-05-23 | 2006-11-22 | $7700.00 | Window Closed / Lapsed |